Published in Brain on April 13, 2006
Memantine (10mg BID) for the Frontal and Temporal Subtypes of Frontotemporal Dementia | NCT00545974
Classification of primary progressive aphasia and its variants. Neurology (2011) 11.82
Neurodegenerative diseases target large-scale human brain networks. Neuron (2009) 9.69
Criteria for the diagnosis of corticobasal degeneration. Neurology (2013) 3.07
REM sleep behavior disorder: Updated review of the core features, the REM sleep behavior disorder-neurodegenerative disease association, evolving concepts, controversies, and future directions. Ann N Y Acad Sci (2010) 2.46
Progressive aphasia secondary to Alzheimer disease vs FTLD pathology. Neurology (2008) 2.45
Characterizing a neurodegenerative syndrome: primary progressive apraxia of speech. Brain (2012) 2.29
Connected speech production in three variants of primary progressive aphasia. Brain (2010) 2.19
Primary progressive aphasia: clinicopathological correlations. Nat Rev Neurol (2010) 2.19
Neuropathological background of phenotypical variability in frontotemporal dementia. Acta Neuropathol (2011) 2.17
Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration. Brain (2011) 2.13
Patterns of cortical thinning in the language variants of frontotemporal lobar degeneration. Neurology (2009) 1.95
Voxel-based morphometry in autopsy proven PSP and CBD. Neurobiol Aging (2006) 1.92
Rates of cerebral atrophy differ in different degenerative pathologies. Brain (2007) 1.90
Clinicopathological correlations in corticobasal degeneration. Ann Neurol (2011) 1.86
Development of methodology for conducting clinical trials in frontotemporal lobar degeneration. Brain (2008) 1.82
White matter damage in primary progressive aphasias: a diffusion tensor tractography study. Brain (2011) 1.73
Frontotemporal lobar degeneration: epidemiology, pathophysiology, diagnosis and management. CNS Drugs (2010) 1.72
Why are patients with progressive nonfluent aphasia nonfluent? Neurology (2010) 1.71
The molecular basis of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum. Ann Med (2012) 1.66
Capturing multidimensionality in stroke aphasia: mapping principal behavioural components to neural structures. Brain (2014) 1.65
Logopenic and nonfluent variants of primary progressive aphasia are differentiated by acoustic measures of speech production. PLoS One (2014) 1.57
Gray and white matter water diffusion in the syndromic variants of frontotemporal dementia. Neurology (2010) 1.57
Asymmetry and heterogeneity of Alzheimer's and frontotemporal pathology in primary progressive aphasia. Brain (2014) 1.54
Dementia induces correlated reductions in white matter integrity and cortical thickness: a multivariate neuroimaging study with sparse canonical correlation analysis. Neuroimage (2010) 1.54
What's new in neuroimaging methods? Ann N Y Acad Sci (2009) 1.53
Temporoparietal atrophy: a marker of AD pathology independent of clinical diagnosis. Neurobiol Aging (2009) 1.46
An autoradiographic evaluation of AV-1451 Tau PET in dementia. Acta Neuropathol Commun (2016) 1.45
The diagnosis of young-onset dementia. Lancet Neurol (2010) 1.37
Oculomotor function in frontotemporal lobar degeneration, related disorders and Alzheimer's disease. Brain (2008) 1.36
Brain and ventricular volumetric changes in frontotemporal lobar degeneration over 1 year. Neurology (2009) 1.34
The non-fluent/agrammatic variant of primary progressive aphasia. Lancet Neurol (2012) 1.33
A novel frontal pathway underlies verbal fluency in primary progressive aphasia. Brain (2013) 1.32
Non-Fluent Speech in Frontotemporal Lobar Degeneration. J Neurolinguistics (2009) 1.30
Word-finding difficulty: a clinical analysis of the progressive aphasias. Brain (2007) 1.27
The early neuropsychological and behavioral characteristics of frontotemporal dementia. Neuropsychol Rev (2008) 1.25
Multimodal predictors for Alzheimer disease in nonfluent primary progressive aphasia. Neurology (2010) 1.24
Anterior insula degeneration in frontotemporal dementia. Brain Struct Funct (2010) 1.24
Frontotemporal dementia: implications for understanding Alzheimer disease. Cold Spring Harb Perspect Med (2012) 1.23
Frontotemporal lobar degeneration: defining phenotypic diversity through personalized medicine. Acta Neuropathol (2014) 1.21
Syndromes dominated by apraxia of speech show distinct characteristics from agrammatic PPA. Neurology (2013) 1.19
Alzheimer's pathology in primary progressive aphasia. Neurobiol Aging (2010) 1.18
Speech errors in progressive non-fluent aphasia. Brain Lang (2010) 1.17
Primary progressive aphasia: a tale of two syndromes and the rest. Neurology (2012) 1.17
Making sense of progressive non-fluent aphasia: an analysis of conversational speech. Brain (2009) 1.14
New approaches to the treatment of frontotemporal lobar degeneration. Curr Opin Neurol (2008) 1.12
Syndromes of nonfluent primary progressive aphasia: a clinical and neurolinguistic analysis. Neurology (2010) 1.11
Task-specific change of unconscious neural priming in the cerebral language network. Proc Natl Acad Sci U S A (2007) 1.11
Symmetric corticobasal degeneration (S-CBD). Parkinsonism Relat Disord (2009) 1.10
Measuring disease progression in frontotemporal lobar degeneration: a clinical and MRI study. Neurology (2010) 1.09
Distinct regional anatomic and functional correlates of neurodegenerative apraxia of speech and aphasia: an MRI and FDG-PET study. Brain Lang (2013) 1.09
Positive effects of language treatment for the logopenic variant of primary progressive aphasia. J Mol Neurosci (2011) 1.05
Apraxia in progressive nonfluent aphasia. J Neurol (2009) 1.04
Anatomical differences between CBS-corticobasal degeneration and CBS-Alzheimer's disease. Mov Disord (2010) 1.03
Primary progressive aphasia and the evolving neurology of the language network. Nat Rev Neurol (2014) 1.02
Disruption of large-scale neural networks in non-fluent/agrammatic variant primary progressive aphasia associated with frontotemporal degeneration pathology. Brain Lang (2012) 1.01
Neuroimaging in frontotemporal lobar degeneration--predicting molecular pathology. Nat Rev Neurol (2012) 0.99
The evolution of primary progressive apraxia of speech. Brain (2014) 0.99
Cognitive and behavioral features of c9FTD/ALS. Alzheimers Res Ther (2012) 0.96
Progranulin-associated primary progressive aphasia: a distinct phenotype? Neuropsychologia (2010) 0.96
The corticobasal syndrome-Alzheimer's disease conundrum. Expert Rev Neurother (2011) 0.95
White matter tract signatures of the progressive aphasias. Neurobiol Aging (2013) 0.95
Cerebrospinal fluid biomarkers for differentiation of frontotemporal lobar degeneration from Alzheimer's disease. Front Aging Neurosci (2013) 0.94
Neuropsychological assessment of patients with dementing illness. Nat Rev Neurol (2011) 0.94
The efficacy of a voxel-based morphometry on the analysis of imaging in schizophrenia, temporal lobe epilepsy, and Alzheimer's disease/mild cognitive impairment: a review. Neuroradiology (2010) 0.93
Neuroimaging biomarkers of neurodegenerative diseases and dementia. Semin Neurol (2013) 0.92
Midbrain atrophy is not a biomarker of progressive supranuclear palsy pathology. Eur J Neurol (2013) 0.92
The new classification of primary progressive aphasia into semantic, logopenic, or nonfluent/agrammatic variants. Curr Neurol Neurosci Rep (2010) 0.91
Statistical parametric mapping demonstrates asymmetric uptake with Tc-99m ECD and Tc-99m HMPAO SPECT in normal brain. J Cereb Blood Flow Metab (2011) 0.91
Neurodegenerative disease phenotypes in carriers of MAPT p.A152T, a risk factor for frontotemporal dementia spectrum disorders and Alzheimer disease. Alzheimer Dis Assoc Disord (2013) 0.90
Frontotemporal lobar degeneration. Neurol Clin (2007) 0.90
The diagnosis and understanding of apraxia of speech: why including neurodegenerative etiologies may be important. J Speech Lang Hear Res (2012) 0.90
The Apraxia of Speech Rating Scale: a tool for diagnosis and description of apraxia of speech. J Commun Disord (2014) 0.89
Receptive prosody in nonfluent primary progressive aphasias. Cortex (2010) 0.88
Progressive supranuclear palsy syndrome presenting as progressive nonfluent aphasia: a neuropsychological and neuroimaging analysis. Mov Disord (2010) 0.88
Nonfluent/agrammatic PPA with in-vivo cortical amyloidosis and Pick's disease pathology. Behav Neurol (2013) 0.88
Characteristics of progressive supranuclear palsy presenting with corticobasal syndrome: a cortical variant. Neuropathol Appl Neurobiol (2014) 0.86
Treatment for apraxia of speech in nonfluent variant primary progressive aphasia. Behav Neurol (2013) 0.85
The neuroanatomy of pure apraxia of speech in stroke. Brain Lang (2014) 0.85
Parkinsonism and frontotemporal dementia: the clinical overlap. J Mol Neurosci (2011) 0.85
In vivo signatures of nonfluent/agrammatic primary progressive aphasia caused by FTLD pathology. Neurology (2013) 0.85
Association of ideomotor apraxia with frontal gray matter volume loss in corticobasal syndrome. Arch Neurol (2009) 0.85
Dominant frontotemporal dementia mutations in 140 cases of primary progressive aphasia and speech apraxia. Dement Geriatr Cogn Disord (2015) 0.84
Neuroimaging comparison of primary progressive apraxia of speech and progressive supranuclear palsy. Eur J Neurol (2012) 0.84
Computerized analysis of speech and language to identify psycholinguistic correlates of frontotemporal lobar degeneration. Cogn Behav Neurol (2010) 0.84
Primary progressive apraxia of speech: clinical features and acoustic and neurologic correlates. Am J Speech Lang Pathol (2015) 0.83
Language, executive function and social cognition in the diagnosis of frontotemporal dementia syndromes. Int Rev Psychiatry (2013) 0.83
Unusual phenotype of pathologically confirmed progressive supranuclear palsy with autonomic dysfunction and cerebellar ataxia: Case report. Medicine (Baltimore) (2016) 0.82
Ideomotor apraxia in agrammatic and logopenic variants of primary progressive aphasia. J Neurol (2013) 0.82
Progranulin-associated PiB-negative logopenic primary progressive aphasia. J Neurol (2014) 0.82
Motor Speech Disorders Associated with Primary Progressive Aphasia. Aphasiology (2014) 0.81
Primary progressive aphasias and their contribution to the contemporary knowledge about the brain-language relationship. Neuropsychol Rev (2011) 0.81
Partially overlapping sensorimotor networks underlie speech praxis and verbal short-term memory: evidence from apraxia of speech following acute stroke. Front Hum Neurosci (2014) 0.81
Grammatical Impairments in PPA. Aphasiology (2014) 0.81
APOE ε4 influences β-amyloid deposition in primary progressive aphasia and speech apraxia. Alzheimers Dement (2014) 0.81
Parkinsonian syndromes. Continuum (Minneap Minn) (2013) 0.81
Structural asymmetry of anterior insula: behavioral correlates and individual differences. Brain Lang (2013) 0.80
Challenges and new opportunities in the investigation of new drug therapies to treat frontotemporal dementia. Expert Opin Ther Targets (2008) 0.80
A multimodal neuroimaging study of a case of crossed nonfluent/agrammatic primary progressive aphasia. J Neurol (2015) 0.80
FDG-PET in pathologically confirmed spontaneous 4R-tauopathy variants. J Neurol (2014) 0.80
Classification and clinicoradiologic features of primary progressive aphasia (PPA) and apraxia of speech. Cortex (2015) 0.80
Voxel-based morphometry--the methods. Neuroimage (2000) 34.79
Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology (1998) 26.77
Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. Arch Neurol (2001) 9.96
Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology (1996) 8.82
Cognition and anatomy in three variants of primary progressive aphasia. Ann Neurol (2004) 7.07
Slowly progressive aphasia without generalized dementia. Ann Neurol (1982) 5.66
Semantic dementia. Progressive fluent aphasia with temporal lobe atrophy. Brain (1992) 5.63
Clinicopathological correlates in frontotemporal dementia. Ann Neurol (2004) 4.38
Clinical and pathological characterization of progressive aphasia. Ann Neurol (2006) 4.37
A new brain region for coordinating speech articulation. Nature (1996) 4.33
Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology (1994) 4.24
The token test: A sensitive test to detect receptive disturbances in aphasics. Brain (1962) 4.12
Differing patterns of temporal atrophy in Alzheimer's disease and semantic dementia. Neurology (2001) 4.10
Primary progressive aphasia. Ann Neurol (2001) 3.72
The evolution and pathology of frontotemporal dementia. Brain (2005) 3.46
Patterns of temporal lobe atrophy in semantic dementia and Alzheimer's disease. Ann Neurol (2001) 3.43
Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia. Ann Neurol (2003) 3.22
Atypical and typical presentations of Alzheimer's disease: a clinical, neuropsychological, neuroimaging and pathological study of 13 cases. Brain (2000) 3.14
Primary progressive aphasia--a language-based dementia. N Engl J Med (2003) 3.14
Comparison of different methodological implementations of voxel-based morphometry in neurodegenerative disease. Neuroimage (2005) 3.06
Office of Rare Diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol (2002) 3.02
The pathological basis of semantic dementia. Brain (2005) 2.96
Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism. Brain (2005) 2.67
Frontotemporal lobar degeneration with motor neuron disease-type inclusions predominates in 76 cases of frontotemporal degeneration. Acta Neuropathol (2004) 2.41
Dementia lacking distinctive histologic features: a common non-Alzheimer degenerative dementia. Neurology (1990) 2.36
Progressive non-fluent aphasia is associated with hypometabolism centred on the left anterior insula. Brain (2003) 2.25
Frontotemporal lobar degeneration and ubiquitin immunohistochemistry. Neuropathol Appl Neurobiol (2004) 2.19
The pathology and nosology of primary progressive aphasia. Neurology (1994) 2.11
Nonfluent progressive aphasia and semantic dementia: a comparative neuropsychological study. J Int Neuropsychol Soc (1996) 2.04
Primary progressive aphasia. Longitudinal course, neuropsychological profile, and language features. Arch Neurol (1990) 2.03
Rapidly progressive aphasic dementia and motor neuron disease. Ann Neurol (1993) 1.93
Progressive Nonfluent Aphasia: Language, Cognitive, and PET Measures Contrasted with Probable Alzheimer's Disease. J Cogn Neurosci (1996) 1.68
Pick's disease. A clinical, computed tomographic, and histologic study with golgi impregnation observations. Arch Neurol (1982) 1.58
Primary progressive aphasia: diagnosis, varieties, evolution. J Int Neuropsychol Soc (2003) 1.56
Comparison of apraxia in corticobasal degeneration and progressive supranuclear palsy. Neurology (2001) 1.51
Clinical, neuroimaging, and pathologic features of progressive nonfluent aphasia. Ann Neurol (1996) 1.45
Semantic dementia with ubiquitin-positive tau-negative inclusion bodies. Brain (2000) 1.43
Alzheimer disease and nonfluent progressive aphasia. Arch Neurol (1996) 1.41
Atypical progressive supranuclear palsy underlying progressive apraxia of speech and nonfluent aphasia. Neurocase (2005) 1.41
Patterns of cerebral atrophy in primary progressive aphasia. Am J Geriatr Psychiatry (2002) 1.34
Heterogeneity in progressive aphasia due to focal cortical atrophy. A clinical and PET study. Brain (1990) 1.23
Clinical, cognitive and anatomical evolution from nonfluent progressive aphasia to corticobasal syndrome: a case report. Neurocase (2004) 1.21
Progressive aphasia in a patient with Pick's disease: a neuropsychological, radiologic, and anatomic study. Neurology (1990) 1.19
Slowly progressive anarthria with late anterior opercular syndrome: a variant form of frontal cortical atrophy syndromes. J Neurol Sci (1996) 1.14
Frontotemporal lobar degeneration with ubiquitin-only-immunoreactive neuronal changes: broadening the clinical picture to include progressive supranuclear palsy. Brain (2004) 1.12
Corticobasal degeneration as a cognitive disorder. Mov Disord (2003) 1.05
Primary progressive aphasia with focal neuronal achromasia. Neurology (1991) 1.04
Apraxia in Parkinson's disease, progressive supranuclear palsy, multiple system atrophy and neuroleptic-induced parkinsonism. Brain (1997) 1.02
Increased tau burden in the cortices of progressive supranuclear palsy presenting with corticobasal syndrome. Mov Disord (2005) 1.01
Focal cortical atrophy syndromes. Brain Cogn (1996) 0.99
Pure progressive aphemia. J Neurol Neurosurg Psychiatry (1993) 0.98
Motor neurone disease, dementia and aphasia: coincidence, co-occurrence or continuum? J Neurol (2001) 0.98
Asymmetric cortical degeneration syndromes. A proposed clinical classification. Arch Neurol (1992) 0.98
Progressive nonfluent aphasia and subsequent aphasic dementia associated with atypical progressive supranuclear palsy pathology. Eur Neurol (2003) 0.96
Motor neuron disease-inclusion dementia presenting as cortical-basal ganglionic degeneration. Mov Disord (1999) 0.96
Establishing a pathological diagnosis in degenerative dementias. Brain Pathol (1998) 0.90
Imaging in primary progressive aphasia. Neuroradiology (1997) 0.89
Pick's disease: a modern approach. Brain Pathol (1998) 0.88
Progressive loss of speech: a neuropsychological profile of premotor dysfunction. Eur Neurol (1998) 0.87
Autosomal dominant progressive syndrome of motor-speech loss without dementia. Neurology (1997) 0.84
Primary progressive non-fluent aphasia: a case study. Cortex (1991) 0.84
Cortical basal ganglionic degeneration presenting with "progressive loss of speech output and orofacial dyspraxia". J Neurol Neurosurg Psychiatry (1992) 0.83
On the role of quantitative brain imaging in the differential diagnosis of speech disorders. Psychiatry Clin Neurosci (2002) 0.83
Asymmetric cortical degeneration syndromes. Curr Opin Neurol (1996) 0.81
The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 24.26
Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 24.02
The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 21.80
Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron (2011) 20.15
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol (2010) 19.42
Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects. Ann Neurol (2009) 14.42
Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron (2004) 14.35
A roadmap for the prevention of dementia II: Leon Thal Symposium 2008. Alzheimers Dement (2009) 10.21
Mild cognitive impairment. Lancet (2006) 10.21
Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke (2011) 10.11
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet (2011) 10.07
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain (2011) 9.90
The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nat Genet (2007) 9.80
11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment. Brain (2008) 9.64
Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA (2010) 9.52
Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol (2013) 9.43
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet (2011) 9.23
Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol (2007) 8.10
Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI). Alzheimers Dement (2005) 7.90
The Alzheimer's disease neuroimaging initiative. Neuroimaging Clin N Am (2005) 7.26
Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease. Brain (2009) 7.20
Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord (2007) 6.92
A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain (2002) 6.85
Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 6.84
Automatic classification of MR scans in Alzheimer's disease. Brain (2008) 6.71
A roadmap for the prevention of dementia: the inaugural Leon Thal Symposium. Alzheimers Dement (2008) 6.39
Neuropathologic features of amnestic mild cognitive impairment. Arch Neurol (2006) 6.20
National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach. Acta Neuropathol (2011) 6.00
TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease. Ann Neurol (2007) 5.98
The Mayo Clinic Study of Aging: design and sampling, participation, baseline measures and sample characteristics. Neuroepidemiology (2008) 5.94
Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS. Neuron (2013) 5.91
Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat Genet (2010) 5.52
Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain (2005) 5.29
Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines. Mov Disord (2012) 5.12
National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease. Alzheimers Dement (2012) 5.10
Protective variant for hippocampal atrophy identified by whole exome sequencing. Ann Neurol (2015) 5.10
The NIH Cognitive and Emotional Health Project. Report of the Critical Evaluation Study Committee. Alzheimers Dement (2006) 5.05
Mild cognitive impairment: ten years later. Arch Neurol (2009) 5.02
Developing a national strategy to prevent dementia: Leon Thal Symposium 2009. Alzheimers Dement (2010) 4.85
Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update. Acta Neuropathol (2009) 4.73
Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: consensus recommendations. Acta Neuropathol (2008) 4.73
Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Arch Neurol (2004) 4.66
The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol (2010) 4.59
Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia. Arch Neurol (2006) 4.56
Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain (2007) 4.50
Alzheimer's disease diagnosis in individual subjects using structural MR images: validation studies. Neuroimage (2007) 4.41
Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease. Brain (2010) 4.39
Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease. Neurobiol Aging (2009) 4.36
An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease. Ann Neurol (2012) 4.36
The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception. Alzheimers Dement (2011) 4.25
Inflammatory cortical demyelination in early multiple sclerosis. N Engl J Med (2011) 4.02
Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease. Nat Genet (2009) 4.00
DCTN1 mutations in Perry syndrome. Nat Genet (2009) 3.87
Longitudinal stability of MRI for mapping brain change using tensor-based morphometry. Neuroimage (2006) 3.85
The Alzheimer's disease neuroimaging initiative: progress report and future plans. Alzheimers Dement (2010) 3.85
Primary age-related tauopathy (PART): a common pathology associated with human aging. Acta Neuropathol (2014) 3.75
Identification of common variants associated with human hippocampal and intracranial volumes. Nat Genet (2012) 3.73